High-dose interleukin-2 in metastatic renal cell carcinoma.
Fernández-Rodríguez
Ricardo
R
de Argumedo
Gonzalo López
GL
Mañé
Juan Manuel
JM
Muñoz
Alberto
A
Ferreiro
Josefa
J
Fuente
Natalia
N
López-Vivanco
Guillermo
G
D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D008297:Male; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D009392:Nephrectomy / Q000379:methods; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D012016:Reference Values; D018570:Risk Assessment; D016019:Survival Analysis; D016896:Treatment Outcome
D007376:Interleukin-2